ID   MLS/ADRR2
AC   CVCL_RB33
SY   MLS/ADR(R2)
DR   Wikidata; Q54905984
RX   PubMed=2715085;
CC   Selected for resistance to: ChEBI; CHEBI_28748; Doxorubicin (Adriablastin; Adriamycin).
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
DI   NCIt; C7978; Ovarian serous cystadenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_RB32 ! MLS
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 19-12-24; Version: 6
//
RX   PubMed=2715085; DOI=10.1016/0360-3016(89)90306-4;
RA   Lee F.Y.F., Siemann D.W.;
RT   "Isolation by flow cytometry of a human ovarian tumor cell
RT   subpopulation exhibiting a high glutathione content phenotype and
RT   increased resistance to adriamycin.";
RL   Int. J. Radiat. Oncol. Biol. Phys. 16:1315-1319(1989).
//